Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. [electronic resource]
- Proceedings of the National Academy of Sciences of the United States of America Nov 1988
- 8037-41 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0027-8424
10.1073/pnas.85.21.8037 doi
Breast Neoplasms--pathology Cell Division--drug effects Cell Line DNA--metabolism Escherichia coli--genetics Humans Interferon Type I--pharmacology Leukemia--pathology Lymphoma--pathology Recombinant Proteins--pharmacology